COSMOS HEALTH NEW DL-01 - Asset Resilience Ratio
COSMOS HEALTH NEW DL-01 (V67A) has an Asset Resilience Ratio of 0.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read V67A liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how COSMOS HEALTH NEW DL-01's Asset Resilience Ratio has changed over time. See net assets of COSMOS HEALTH NEW DL-01 for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down COSMOS HEALTH NEW DL-01's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see COSMOS HEALTH NEW DL-01 stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €46.16K | 0.07% |
| Total Liquid Assets | €46.16K | 0.07% |
Asset Resilience Insights
- Limited Liquidity: COSMOS HEALTH NEW DL-01 maintains only 0.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
COSMOS HEALTH NEW DL-01 Industry Peers by Asset Resilience Ratio
Compare COSMOS HEALTH NEW DL-01's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998 |
Medical Distribution | 0.08% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
Annual Asset Resilience Ratio for COSMOS HEALTH NEW DL-01 (2021–2025)
The table below shows the annual Asset Resilience Ratio data for COSMOS HEALTH NEW DL-01.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.07% | €46.16K ≈ $53.96K |
€65.48 Million ≈ $76.55 Million |
+0.03pp |
| 2024-12-31 | 0.04% | €21.15K ≈ $24.72K |
€54.31 Million ≈ $63.50 Million |
+0.01pp |
| 2023-12-31 | 0.03% | €20.07K ≈ $23.47K |
€66.01 Million ≈ $77.18 Million |
+0.01pp |
| 2022-12-31 | 0.02% | €14.88K ≈ $17.40K |
€68.04 Million ≈ $79.54 Million |
0.00pp |
| 2021-12-31 | 0.02% | €11.47K ≈ $13.41K |
€49.43 Million ≈ $57.79 Million |
-- |
About COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more